Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Hum Mutat. 2019 Oct 26;41(1):316–331. doi: 10.1002/humu.23930

Figure 4.

Figure 4.

I/Cl antiport assay. (a) A fluorescence microscopic image of cells expressing WT-pendrin-mTq2 (doxycycline-induced) and mVenus p.H148Q/p.I152L (constitutively expressed). The fluorescence of mVenus p.H148Q/p.I152L is sensitive to I, and thus can be used as an intracellular I indicator. (b) The optical configuration of Synergy Neo2 plate reader used for the assay. See also Supp. Fig. S1 for detail. (c) Time-dependent change of mVenus p.H148Q/p.I152L fluorescence (after correction, black circles) and intracellular iodide (red triangle). See the main text for detail. (d) Response of mVenus p.H148Q/p.I152L fluorescence to I. The affinity of mVenus p.H148Q/p.I152L to I was determined to be 10.6 mM. This constant was used to convert the corrected mVenus p.H148Q/p.I152L fluorescence into intracellular I concentration. (e and f) I/Cl antiport assays for WT- and p.Arg409His-pendrin-expressing cells, respectively. The broken lines indicate the initial rates. (g) Summaries of doxycycline dosage-dependent I/Cl antiport assay shown in panels e and f. The broken lines indicate the basal transport activity determined for non-induced cells (negative control).